CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS) today announced financial results for the second quarter ended June 30, 2011. “Our Q2 results demonstrate continuing execution toward our guidance of 20% total revenue growth for 2011. We also recently engaged new distributors in Israel, South Africa, Mexico and Brazil to strengthen our foundation for future growth,” said William “Obi” Greenman, president and chief executive officer of Cerus Corporation. “Further, we’re finalizing preparations for our European Phase 3 red cell trial and preparing for FDA discussions this fall regarding all three INTERCEPT programs.”
